2025
SJR Q2
JCR Q2 · 2,7
SCIE
Dergi ayrıntısı
Cellular Reprogramming
- Yayıncı
- Mary Ann Liebert Inc.
- Ülke
- United States · Northern America
- Tür
- journal
- ISSN
-
2152497121524998
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 0,553
- Quartile Q2
- H-Index 67
- Atıf/yayın 1,76
- Doküman (3y) 101
- Atıf (3y) 163
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 2,7
- 5Y JIF 1,7
- JCI 0,39
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
- Biotechnology Q2
- Cell Biology Q4
- Developmental Biology Q3
Alanlar
- Biochemistry, Genetics and Molecular Biology
WoS kategorileri
- Cell & Tissue Engineering | Biotechnology & Applied Microbiology | Genetics & Heredity
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q2 | 0,553 | 2,7 | 1,7 | 0,39 | Q4 | 67 |
| 2024 | Q3 | Q3 | 0,45 | 1,7 | 1,5 | 0,34 | Q4 | 66 |
| 2023 | Q3 | Q4 | 0,316 | 1,2 | 1,7 | 0,31 | Q4 | 66 |
| 2022 | Q3 | Q4 | 0,375 | 1,6 | 1,9 | 0,4 | Q4 | 66 |
| 2021 | Q3 | Q4 | 0,392 | 2,3 | 2,1 | 0,44 | Q3 | 66 |
| 2020 | Q3 | Q4 | 0,517 | 2 | 1,9 | 0,45 | Q4 | 66 |
| 2019 | Q3 | Q4 | 0,495 | 1,7 | 1,6 | 0,41 | Q4 | 66 |
| 2018 | — | Q4 | — | 1,5 | 1,7 | 0,41 | Q4 | — |
| 2017 | Q2 | Q4 | 0,549 | 1,4 | 1,6 | 0,41 | Q4 | 66 |
| 2016 | Q2 | Q4 | 0,676 | 1,3 | 1,5 | — | — | 66 |
| 2015 | Q2 | Q3 | 0,72 | 1,5 | 1,8 | — | — | 66 |
| 2014 | Q2 | Q3 | 0,877 | 1,8 | 2,1 | — | — | 66 |
| 2013 | Q1 | Q2 | 1,058 | 2,3 | 2,5 | — | — | 66 |
| 2012 | Q1 | Q2 | 1,013 | 2,7 | 2,8 | — | — | 66 |
| 2011 | Q1 | Q2 | 1,252 | 2,3 | 2,3 | — | — | 66 |
| 2010 | Q2 | — | 0,984 | — | — | — | — | 66 |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q3 | Q4 | 112/180 |
| 2025 | CELL & TISSUE ENGINEERING | SCIE | Q3 | Q4 | 24/32 |
| 2025 | GENETICS & HEREDITY | SCIE | Q2 | Q4 | 92/192 |
| 2024 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q4 | Q4 | 138/177 |
| 2024 | CELL & TISSUE ENGINEERING | SCIE | Q4 | Q4 | 30/32 |
| 2024 | GENETICS & HEREDITY | SCIE | Q3 | Q4 | 135/192 |
| 2023 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q4 | Q4 | 162/174 |
| 2023 | CELL & TISSUE ENGINEERING | SCIE | Q4 | Q4 | 29/31 |
| 2023 | GENETICS & HEREDITY | SCIE | Q4 | Q4 | 162/191 |
| 2022 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q4 | Q4 | 136/158 |
| 2022 | CELL & TISSUE ENGINEERING | SCIE | Q4 | Q4 | 27/29 |
| 2022 | GENETICS & HEREDITY | SCIE | Q4 | Q4 | 144/171 |
| 2021 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q4 | Q4 | 130/159 |
| 2021 | CELL & TISSUE ENGINEERING | SCIE | Q4 | Q4 | 27/29 |
| 2021 | GENETICS & HEREDITY | SCIE | Q4 | Q3 | 132/175 |
| 2020 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q4 | Q4 | 134/159 |
| 2020 | CELL & TISSUE ENGINEERING | SCIE | Q4 | Q4 | 28/29 |
| 2020 | GENETICS & HEREDITY | SCIE | Q4 | Q4 | 138/176 |
| 2019 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q4 | Q4 | 123/156 |
| 2019 | CELL & TISSUE ENGINEERING | SCIE | Q4 | Q4 | 28/29 |
| 2019 | GENETICS & HEREDITY | SCIE | Q4 | Q4 | 136/178 |
| 2018 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q4 | Q4 | 132/162 |
| 2018 | CELL & TISSUE ENGINEERING | SCIE | Q4 | Q4 | 24/26 |
| 2018 | GENETICS & HEREDITY | SCIE | Q4 | Q4 | 139/174 |
| 2017 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q4 | Q4 | 123/161 |
| 2017 | CELL & TISSUE ENGINEERING | SCIE | Q4 | Q4 | 21/24 |
| 2017 | GENETICS & HEREDITY | SCIE | Q4 | Q4 | 142/171 |
| 2016 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q4 | — | 127/160 |
| 2016 | CELL & TISSUE ENGINEERING | SCIE | Q4 | — | 20/21 |
| 2016 | GENETICS & HEREDITY | SCIE | Q4 | — | 140/167 |
| 2015 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q3 | — | 116/161 |
| 2015 | CELL & TISSUE ENGINEERING | SCIE | Q4 | — | 19/21 |
| 2015 | GENETICS & HEREDITY | SCIE | Q4 | — | 136/166 |
| 2014 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q3 | — | 92/163 |
| 2014 | CELL & TISSUE ENGINEERING | SCIE | Q4 | — | 17/21 |
| 2014 | GENETICS & HEREDITY | SCIE | Q3 | — | 119/167 |
| 2013 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | — | 72/165 |
| 2013 | CELL & TISSUE ENGINEERING | SCIE | Q4 | — | 15/18 |
| 2013 | GENETICS & HEREDITY | SCIE | Q3 | — | 100/165 |
| 2012 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | — | 53/160 |
| 2012 | CELL & TISSUE ENGINEERING | SCIE | Q4 | — | 13/17 |
| 2012 | GENETICS & HEREDITY | SCIE | Q2 | — | 75/161 |
| 2011 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | — | 72/158 |
| 2011 | CELL & TISSUE ENGINEERING | SCIE | Q4 | — | 11/12 |
| 2011 | GENETICS & HEREDITY | SCIE | Q3 | — | 97/158 |
| 2010 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | — | — | — |
| 2010 | CELL & TISSUE ENGINEERING | SCIE | — | — | — |
| 2010 | GENETICS & HEREDITY | SCIE | — | — | — |